RecruitingNCT06774729

Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor

Development of a Radiomics Model With 3T Multiparametric MR to Predict the Occurence of a Perilesional Infiltration of Muscoskeletal Tumor During the Pre- Surgery Planning


Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Enrollment

122 participants

Start Date

Mar 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS). The main questions it aims to answer are: * is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results? * is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease? Participants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age over 18
  • suspect of soft tissue sarcoma with a indication for surgical treatment
  • suspect of bone cancer tumor with a indication for surgical treatment
  • To give informed consent

Exclusion Criteria10

  • simultaneous cancer or history of cancer in the last 5 years
  • acute or chronic serious conditions that could
  • contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI) such as:
  • renal failure without dialysis
  • history of allergy to a paramagnetic contrast agent
  • claustrophobia
  • symptomatic epilepsy or history of epilepsy
  • cardiac pacemaker
  • infusion pump, prosthesis or any implant not compatible with MRI
  • pregnancy

Locations(1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06774729


Related Trials